US Omega-3 Supplement Firm Changes Claims On Amarin Challenge, But Not Label Or Company Name

Fish-Oil Based Drug Marketer's Latest Challenge To Omega-3 Claims Is NAD Review

• Source: Alamy
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Compliance

More from Policy & Regulation